Healthcare & Life Sciences
Orpheris
United States
acquiredacquired
acquired
Stage
About
Orpheris was a biopharmaceutical company focused on developing therapeutic drugs. It is listed as a portfolio company of Catalio Capital that exited in 2021.
Explore Orpheris's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.